102 related articles for article (PubMed ID: 2087187)
1. Retinoid modulation of phorbol ester effects in skin.
Gendimenico GJ; Capetola RJ; Rosenthale ME; McGuire JL; Mezick JA
Methods Enzymol; 1990; 190():346-52. PubMed ID: 2087187
[No Abstract] [Full Text] [Related]
2. Retinoids and inhibition of ornithine decarboxylase activity.
Boutwell RK
J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):796-800. PubMed ID: 7068980
[TBL] [Abstract][Full Text] [Related]
3. Dose and schedule of oral retinoic acid and indomethacin needed to effectively inhibit phorbol ester-induced epidermal ornithine decarboxylase activity.
Loprinzi CL; Verma AK
Carcinogenesis; 1985 Nov; 6(11):1589-92. PubMed ID: 4053280
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of phorbol ester tumor promoter 12-O-tetradecanoylphorbol-13-acetate-caused inflammatory responses in SENCAR mouse skin by black tea polyphenols.
Katiyar SK; Mukhtar H
Carcinogenesis; 1997 Oct; 18(10):1911-6. PubMed ID: 9363999
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine inhibits ornithine decarboxylase gene expression and acute inflammation in response to phorbol ester treatment of hairless mouse skin.
Elder JT; Gupta AK; Fisher GJ; Voorhees JJ
Transplant Proc; 1988 Jun; 20(3 Suppl 4):95-104. PubMed ID: 3381308
[No Abstract] [Full Text] [Related]
6. Effect of retinoic acid pretreatment on 12-O-tetradecanoylphorbol-13-acetate-induced cell population kinetics and polyamine biosynthesis in hairless mouse epidermis.
Astrup EG; Paulsen JE
Carcinogenesis; 1982; 3(3):313-20. PubMed ID: 7083472
[TBL] [Abstract][Full Text] [Related]
7. Vitamin A acid (retinoic acid), a potent inhibitor of 12-O-tetradecanoyl-phorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis.
Verma AK; Boutwell RK
Cancer Res; 1977 Jul; 37(7 Pt 1):2196-201. PubMed ID: 861945
[No Abstract] [Full Text] [Related]
8. all-trans-Retinoic acid inhibits the appearance of two phorbol ester-induced ornithine decarboxylase mRNAs in mouse epidermis.
Kumar S; de Vellis J; Lowe NJ; Weingarten DP
FEBS Lett; 1986 Nov; 208(1):151-4. PubMed ID: 3770209
[TBL] [Abstract][Full Text] [Related]
9. Prostratin, a nonpromoting phorbol ester, inhibits induction by phorbol 12-myristate 13-acetate of ornithine decarboxylase, edema, and hyperplasia in CD-1 mouse skin.
Szallasi Z; Blumberg PM
Cancer Res; 1991 Oct; 51(19):5355-60. PubMed ID: 1913657
[TBL] [Abstract][Full Text] [Related]
10. Differential inhibition by staurosporine, a potent protein kinase C inhibitor, of 12-O-tetradecanoylphorbol-13-acetate-caused skin tumor promotion, epidermal ornithine decarboxylase induction, hyperplasia and inflammation.
Yamamoto S; Kiyoto I; Aizu E; Nakadate T; Hosoda Y; Kato R
Carcinogenesis; 1989 Jul; 10(7):1315-22. PubMed ID: 2544313
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of phorbol ester-caused synthesis of mouse epidermal ornithine decarboxylase by retinoic acid.
Verma AK
Biochim Biophys Acta; 1985 Jul; 846(1):109-19. PubMed ID: 2861859
[TBL] [Abstract][Full Text] [Related]
12. BMY 30047: a novel topically active retinoid with low local and systemic toxicity.
Nair X; Quigley J; Tramposch KM; Carroll FI; Lewin AH; Kiss I
J Pharmacol Exp Ther; 1991 Jan; 256(1):365-70. PubMed ID: 1988666
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effect of sn-1,2-didecanoylglycerol and 12-O-tetradecanoylphorbol-13-acetate on cutaneous morphology, inflammation and tumor promotion in CD-1 mice.
Smart RC; Huang MT; Monteiro-Riviere NA; Wong CQ; Mills KJ; Conney AH
Carcinogenesis; 1988 Dec; 9(12):2221-6. PubMed ID: 3191568
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of phorbol esters on c-fos and c-myc and ornithine decarboxylase gene expression in mouse skin in vivo.
Rose-John S; Fürstenberger G; Krieg P; Besemfelder E; Rincke G; Marks F
Carcinogenesis; 1988 May; 9(5):831-5. PubMed ID: 3365842
[TBL] [Abstract][Full Text] [Related]
15. Characterization of an inbred strain of the SENCAR mouse that is highly sensitive to phorbol esters.
Fischer SM; O'Connell JF; Conti CJ; Tacker KC; Fries JW; Patrick KE; Adams LM; Slaga TJ
Carcinogenesis; 1987 Mar; 8(3):421-4. PubMed ID: 3545526
[TBL] [Abstract][Full Text] [Related]
16. Correlation of the inhibition by retinoids of tumor promoter-induced mouse epidermal ornithine decarboxylase activity and of skin tumor promotion.
Verma AK; Shapas BG; Rice HM; Boutwell RK
Cancer Res; 1979 Feb; 39(2 Pt 1):419-25. PubMed ID: 761215
[No Abstract] [Full Text] [Related]
17. Topical tretinoin prevents corticosteroid-induced atrophy without lessening the anti-inflammatory effect.
Kligman LH; Schwartz E; Lesnik RH; Mezick JA
Curr Probl Dermatol; 1993; 21():79-88. PubMed ID: 8299380
[No Abstract] [Full Text] [Related]
18. Correlation of phorbol ester promotion in the resistant C57BL/6J mouse with sustained hyperplasia but not ornithine decarboxylase or protein kinase C.
Fischer SM; Jasheway DW; Klann RC; Butler AP; Patrick KE; Baldwin JK; Cameron GS
Cancer Res; 1989 Dec; 49(23):6693-9. PubMed ID: 2819717
[TBL] [Abstract][Full Text] [Related]
19. Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin.
Lee JY; Shin JW; Chun KS; Park KK; Chung WY; Bang YJ; Sung JH; Surh YJ
Carcinogenesis; 2005 Feb; 26(2):359-67. PubMed ID: 15498788
[TBL] [Abstract][Full Text] [Related]
20. Modulation of mouse skin tumor promotion by dietary 13-cis-retinoic acid and alpha-difluoromethylornithine.
Verma AK; Duvick L; Ali M
Carcinogenesis; 1986 Jun; 7(6):1019-23. PubMed ID: 3085964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
